Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us
Opportunity Analyzer Allergic Conjunctivitis Opportunity Analysis and Forecasts to 2018
Summary
The allergic conjunctivitis market has remained relatively static over the last few years, due to a limited number of new products. It is currently dominated by dual-acting products and corticosteroid therapies, which form the core treatment options for both acute and chronic allergic conjunctivitis sufferers. Although these therapies provide effective treatment regimens, there are opportunities for the development of alternative treatment choices, improvements in efficacy, safety and compliance. By 2018, there will be three new entrants to the allergic conjunctivitis market. These new products will help drive market growth and offset the impending patent expiries of the majority of the remaining brands (Lotemax, Patanol and Lastacaft) during the forecast period, which will permit the entry of inexpensive generics. Despite these advancements in the treatment landscape, the allergic conjunctivitis market is not expected to experience a noticeable change in terms of growth.
To Browse a Full Report with Toc: http://www.researchmoz.us/opportunityanalyzer-allergic-conjunctivitis-opportunity-analysis-and-forecasts-to-2018-report.html
Key Findings
- The main driver of the expansion of the allergic conjunctivitis market will be the introduction of three new therapies across the 6 major markets.
- The biggest barrier for the introduction of new therapies will be patent expirations of the majority of the drugs marketed for allergic conjunctivitis, which will result in an increase of generics, and which may negatively impact revenue from branded drugs that are expected to launch in the forecast period.
- The concerns of reducing healthcare costs as part of government austerity measures, particularly in Europe, which will impede market growth. To ensure reimbursement companies will have to work closely together with payers and price their drugs competitively.
Scope
- Overview of allergic conjunctivitis, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized allergic conjunctivitis therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for five years to 2018.
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the allergic conjunctivitis therapeutics market.
- Pipeline analysis: focus on the five late-stage pipeline drugs discussing emerging trends as well as overview of earlier phase drugs.
- Analysis of the current and future market competition in the global allergic conjunctivitis therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global allergic conjunctivitis therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global allergic conjunctivitis therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
7.1.7 Future Trial Design 87
8 Pipeline Assessment 88
8.1 Overview 88
8.2 Promising Drugs in Clinical Development 89
8.2.1 Vekacia (cyclosporine) 90
8.2.2 SUN-1334H (antihistamine) 95
8.2.3 OTX-DP (dexamethasone) 97
8.2.4 RX-10045 (resolvin) 101
8.2.5 AC-170 (cetirizine) 105
8.3 Innovative Early-Stage Approaches 108
9 Pipeline Valuation Analysis 111
9.1 Clinical Benchmarking of Key Pipeline Drugs 111
9.2 Commercial Benchmark of Key Pipeline Drugs 114
9.3 Competitive Assessment 117
9.4 Top-Line Five-Year Forecast 119
1.1 List of Tables
Table 1: Characteristics of Allergic Conjunctivitis Subtypes 19
Table 2: Risk Factors and Comorbidities for Allergic Conjunctivitis 28
Table 3: 6MM, Sources of Allergic Conjunctivitis Prevalence Data Used in the Epidemiology Forecast 30
Table 4: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, All Ages, Both Sexes, N, 2013-2023 34
Table 5: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Age, Both Sexes, N (Row %), 2013 35
Table 6: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Sex, All Ages, N (Row %), 2013 37
Table 7: Leading Treatments for Allergic Conjunctivitis 42
Table 8: Product Profile -Antihistamines 43
Table 9: Antihistamines SWOT Analysis 45
To Browse a Full Report with Toc: http://www.researchmoz.us/opportunityanalyzer-allergic-conjunctivitis-opportunity-analysis-and-forecasts-to-2018-report.html
All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact US:
For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463
Opportunity Analyzer Allergic Conjunctivitis Opportunity Analysis and Forecasts to 2018
Summary
The allergic conjunctivitis market has remained relatively static over the last few years, due to a limited number of new products. It is currently dominated by dual-acting products and corticosteroid therapies, which form the core treatment options for both acute and chronic allergic conjunctivitis sufferers. Although these therapies provide effective treatment regimens, there are opportunities for the development of alternative treatment choices, improvements in efficacy, safety and compliance. By 2018, there will be three new entrants to the allergic conjunctivitis market. These new products will help drive market growth and offset the impending patent expiries of the majority of the remaining brands (Lotemax, Patanol and Lastacaft) during the forecast period, which will permit the entry of inexpensive generics. Despite these advancements in the treatment landscape, the allergic conjunctivitis market is not expected to experience a noticeable change in terms of growth.
To Browse a Full Report with Toc: http://www.researchmoz.us/opportunityanalyzer-allergic-conjunctivitis-opportunity-analysis-and-forecasts-to-2018-report.html
Key Findings
- The main driver of the expansion of the allergic conjunctivitis market will be the introduction of three new therapies across the 6 major markets.
- The biggest barrier for the introduction of new therapies will be patent expirations of the majority of the drugs marketed for allergic conjunctivitis, which will result in an increase of generics, and which may negatively impact revenue from branded drugs that are expected to launch in the forecast period.
- The concerns of reducing healthcare costs as part of government austerity measures, particularly in Europe, which will impede market growth. To ensure reimbursement companies will have to work closely together with payers and price their drugs competitively.
Scope
- Overview of allergic conjunctivitis, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized allergic conjunctivitis therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for five years to 2018.
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the allergic conjunctivitis therapeutics market.
- Pipeline analysis: focus on the five late-stage pipeline drugs discussing emerging trends as well as overview of earlier phase drugs.
- Analysis of the current and future market competition in the global allergic conjunctivitis therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global allergic conjunctivitis therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global allergic conjunctivitis therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
7.1.7 Future Trial Design 87
8 Pipeline Assessment 88
8.1 Overview 88
8.2 Promising Drugs in Clinical Development 89
8.2.1 Vekacia (cyclosporine) 90
8.2.2 SUN-1334H (antihistamine) 95
8.2.3 OTX-DP (dexamethasone) 97
8.2.4 RX-10045 (resolvin) 101
8.2.5 AC-170 (cetirizine) 105
8.3 Innovative Early-Stage Approaches 108
9 Pipeline Valuation Analysis 111
9.1 Clinical Benchmarking of Key Pipeline Drugs 111
9.2 Commercial Benchmark of Key Pipeline Drugs 114
9.3 Competitive Assessment 117
9.4 Top-Line Five-Year Forecast 119
1.1 List of Tables
Table 1: Characteristics of Allergic Conjunctivitis Subtypes 19
Table 2: Risk Factors and Comorbidities for Allergic Conjunctivitis 28
Table 3: 6MM, Sources of Allergic Conjunctivitis Prevalence Data Used in the Epidemiology Forecast 30
Table 4: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, All Ages, Both Sexes, N, 2013-2023 34
Table 5: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Age, Both Sexes, N (Row %), 2013 35
Table 6: 6MM, Total Prevalent Cases of Allergic Conjunctivitis, by Sex, All Ages, N (Row %), 2013 37
Table 7: Leading Treatments for Allergic Conjunctivitis 42
Table 8: Product Profile -Antihistamines 43
Table 9: Antihistamines SWOT Analysis 45
To Browse a Full Report with Toc: http://www.researchmoz.us/opportunityanalyzer-allergic-conjunctivitis-opportunity-analysis-and-forecasts-to-2018-report.html
All Reports of this Category Here: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact US:
For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://mresearchreports.blogspot.com/
Get More Market Research Report : https://www.linkedin.com/today/author/355409463
No comments:
Post a Comment